Crossmark

A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma

Published Online: 2020-08-11

Published Print: 2020-10

Authors

Liu, Wen

Li, Huilan

Sheng, Hui

Liu, Xiaohua

Chi, Peidong

Wang, Xueping

Mao, Minjie https://orcid.org/0000-0002-5250-8186
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81871711)
License Information

Text and Data Mining valid from 2020-08-11

Version of Record valid from 2020-08-11
More Information

Article History

Received: 30 June 2020

First Online: 11 August 2020

Document is current